Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer
Status:
Unknown status
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the pathologic complete response rate to pre-operative concurrent
chemoradiotherapy with capecitabine plus irinotecan in resectable rectal cancer